Almudena Navarro‐Bailón

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia

Hardikkumar Jetani, Almudena Navarro‐Bailón, Marius Maucher et al. · Blood · 2021 · 100 citations · Full text

Medicine, Immunology, Oncology +16

Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia

Alejandro M. Hortal, Clara L. Oeste, Claudia Cifuentes et al. · Molecular Cancer · 2022 · 51 citations · Full text

Life Sciences, Genetics, Oncology +17

Short Tandem Repeats (STRs) as Biomarkers for the Quantitative Follow-Up of Chimerism after Stem Cell Transplantation: Methodological Considerations and Clinical Application

Almudena Navarro‐Bailón, Diego Carbonell, Asunción Escudero et al. · Genes · 2020 · 35 citations · Full text

Medicine, Hematology, Molecular Biology +14

Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

Thomas Chatzikonstantinou, Lydia Scarfò, Georgios Karakatsoulis et al. · EClinicalMedicine · 2023 · 19 citations · Full text

Medicine, Hematology, Oncology +16

Inhibitory killer cell immunoglobulin‐like receptor (<scp>iKIR</scp>) mismatches improve survival after T‐cell‐repleted haploidentical transplantation

Mariana Bastos‐Oreiro, Javier Anguita, Carolina Martínez‐Laperche et al. · European Journal Of Haematology · 2015 · 18 citations

Life Sciences, Hematology, Immunology +16